Top1000 Scholar

Scholarly Index

Benjamin Besse

Institut Gustave Roussy; 54,086 total citations; 1,257 total publications; best world rank #9

Institut Gustave Roussy

54,086Total citations
1,257Total publications
100H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Lung Cancer Treatments and MutationsLifetime45FR 399.84
Lung Cancer Research StudiesLifetime39FR 299.79
Cancer Immunotherapy and BiomarkersLifetime95FR 999.74
Lung Cancer Diagnosis and TreatmentLifetime120FR 399.58
Cancer Genomics and DiagnosticsLifetime208FR 899.55
Colorectal Cancer Treatments and StudiesLifetime219FR 2199.23
Cancer therapeutics and mechanismsLifetime197FR 698.82
Brain Metastases and TreatmentLifetime202FR 1098.44
Myasthenia Gravis and ThymomaLifetime178FR 997.25
Neuroendocrine Tumor Research AdvancesLifetime607FR 3098.00
Peptidase Inhibition and AnalysisLifetime831FR 3397.39
HER2/EGFR in Cancer ResearchLifetime916FR 4596.39
PI3K/AKT/mTOR signaling in cancerLifetime624FR 2195.52
Advanced Breast Cancer TherapiesLifetime828FR 4393.60
Cancer Immunotherapy and Biomarkers2021-202516FR 399.92
Lung Cancer Treatments and Mutations2021-20259FR 199.95
Cancer Genomics and Diagnostics2021-202517FR 399.77
Lung Cancer Research Studies2021-202510FR 199.89
Lung Cancer Diagnosis and Treatment2021-202520FR 299.67
Colorectal Cancer Treatments and Studies2021-202533FR 599.45
Gastric Cancer Management and Outcomes2021-2025183FR 998.20
Immunotherapy and Immune Responses2021-2025177FR 1297.30
Cancer therapeutics and mechanisms2021-202582FR 293.82
Neuroendocrine Tumor Research Advances2021-2025250FR 1694.61
Myasthenia Gravis and Thymoma2021-2025106FR 493.06
Cancer Diagnosis and Treatment2021-2025229FR 1088.11
HER2/EGFR in Cancer Research2021-2025669FR 3689.35
Multiple and Secondary Primary Cancers2021-2025326FR 2081.80
PARP inhibition in cancer therapy2021-2025717FR 4482.31
Melanoma and MAPK Pathways2021-2025637FR 2375.13
Occupational and environmental lung diseases2021-2025840FR 4571.23